MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Avalon Ventures
Ambit Biosciences Corp (NASDAQ:AMBI).
Finance & Acquisition: Ambit
Parents
Ambit Biosciences Corp (NASDAQ:AMBI).
Children
Ambit Biosciences Completes $30 Million Series D-2 Financing (2011)
Ambit Biosciences, Inc. Series D $30M by OnBioVC (2011)
Ambit Raises $30M Venture Round, After Pulling Plug on IPO (2011)
Ambit says it has raised more than $105 million over the past 11 years (2011)
Ambit Withdraws IPO (2011)
Gross IPO Proceeds (2013):Ambit-AMBI=$83 million
Investors include Avalon Ventures, Forward Ventures, Genechem, GIMV, Horizon Technology Finance, Jov-CMDF, MedImmune Ventures, N
Investors led by Apposite Capital, Perseus-Soros Biopharmaceutical Fund, OrbiMed Advisors, Forward Ventures, Roche Venture Fund, MedImmune Ventures, GIMV, GrowthWorks, Genechem, Radius Ventures, NovaQuest and Horizon Technology Finance.
Jumps
*Key People: Ambit
Organization & Developments: Ambit